Thyroid hormones and cardiac arrhythmias
Bloating is one of the most common side effects experienced by patients taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
Segn las guas de la American Diabetes Association (ADA), los agonistas del receptor GLP-1 con beneficio cardiovascular demostrado se recomiendan para pacientes con diabetes tipo 2 que tienen enfermedad cardiovascular aterosclertica o alto riesgo cardiovascular, independientemente del uso de metformina
Oftentimes, too-high levels of oxidative stress and Glutathione depletion can lead to multiple diseases, including neurodegenerative disorders (Alzheimers, Parkinsons), pulmonary disease (asthma, COPD), immune disease (HIV, autoimmune disease), cardiovascular diseases (hypertensions), liver disease, cystic fibrosis, and aging
985-P: Oral semaglutide as add-on to insulin in T2D: PIONEER 8